[Federal Register: April 14, 2003 (Volume 68, Number 71)]
[Notices]
[Page 17960]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr14ap03-66]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Vaccines and Related Biological Products Advisory Committee;
Notice of Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). At least one
portion of the meeting will be closed to the public.
Name of Committee: Vaccines and Related Biological Products
Advisory Committee.
General Function of the Committee: To provide advice and
recommendations to the agency on FDA's regulatory issues.
Date and Time: The meeting will be held on May 8, 2003, from 1:30
p.m. to 4 p.m.
Location: Food and Drug Administration, 29 Lincoln Dr., bldg. 29B,
conference room A, Bethesda, MD. This meeting will be held by a
telephone conference call. The public is welcome to attend the open
session of the meeting at the specified location.
Contact Person: Jody G. Sachs or Denise H. Royster, Food and Drug
Administration, Center for Biologics Evaluation and Research (HFM-71),
301 827-0314, or FDA Advisory Committee Information Line, 1-800-741-
8138 (301-443-0572 in the Washington, DC area), code 12391. Please call
the Information Line for up-to-date information on this meeting.
Agenda: The committee will review and discuss the intramural
research programs of the Laboratory of Mycobacterial Diseases &
Cellular Immunology and the Laboratory of Method Development, in the
Office of Vaccines Research and Review.
Procedure: On May 8, 2003, from 1:30 p.m. to 3:30 p.m., the meeting
is open to the public. Interested persons may present data,
information, or views, orally or in writing, on issues pending before
the committee. Written submissions may be made to the contact person by
April 25, 2003. Oral presentations from the public will be scheduled
between approximately 2:30 p.m. and 3:30 p.m. Time allotted for each
presentation may be limited. Those desiring to make formal oral
presentations should notify the contact person before April 25, 2003,
and submit a brief statement of the general nature of the evidence or
arguments they wish to present, the names and addresses of proposed
participants, and an indication of the approximate time requested to
make their presentation.
Closed Committee Deliberations: On May 8, 2003, from 3:30 p.m. to 4
p.m., the meeting will be closed to permit discussion where disclosure
would constitute a clearly unwarranted invasion of personal privacy (5
U.S.C. 552b(c)(6)). The meeting will be closed to discuss personal
information concerning individuals associated with the intramural
laboratory research programs.
Persons attending FDA's advisory committee meetings are advised
that the agency is not responsible for providing access to electrical
outlets.
FDA welcomes the attendance of the public at its advisory committee
meetings and will make every effort to accommodate persons with
physical disabilities or special needs. If you require special
accommodations due to a disability, please contact Jody G. Sachs or
Denise H. Royster at least 7 days in advance of the meeting.
Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).
Dated: April 7, 2003.
Linda Arey Skladany,
Associate Commissioner for External Relations.
[FR Doc. 03-9030 Filed 4-11-03; 8:45 am]
BILLING CODE 4160-01-S